This meta-analysis compared anti-EGFR to anti-VEGF therapy when combined with FOLFIRI or FOLFOX chemotherapy, as first-line treatment for advanced or metastatic colorectal cancer. The gene discussed is VEGFA; the disease is metastatic colorectal cancer.